Literature DB >> 15598883

Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets.

Satoshi Kubota1, Kazumi Kawata, Takeshi Yanagita, Hideyuki Doi, Takashi Kitoh, Masaharu Takigawa.   

Abstract

Wound healing and tissue regeneration are usually initiated by coagulation followed by fibrous tissue formation. In the present study, we discovered an abundance of connective tissue growth factor (CTGF/CCN2) in human platelets, which was released along with the coagulation process. The CTGF/CCN2 content in platelets was 10-fold higher than that in arterial tissue. Furthermore, the CTGF/CCN2 content in a single platelet was computed to be more than 20-fold higher than that of any other growth factor reported. Considering that CTGF/CCN2 promotes angiogenesis, cartilage regeneration, fibrosis and platelet adhesion, it may be now regarded as one of the major functional components of platelets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598883     DOI: 10.1093/jb/mvh126

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  27 in total

Review 1.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  The use of autologous blood-derived growth factors in bone regeneration.

Authors:  Roberto Civinini; Armando Macera; Lorenzo Nistri; Birgit Redl; Massimo Innocenti
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

Review 3.  Platelet-rich plasma and platelet gel: a review.

Authors:  Peter A M Everts; Johannes T A Knape; Gernot Weibrich; Jacques P A M Schönberger; Johannes Hoffmann; Eddy P Overdevest; Henk A M Box; André van Zundert
Journal:  J Extra Corpor Technol       Date:  2006-06

4.  Association of the metastatic phenotype with CCN family members among breast and oral cancer cells.

Authors:  Toshihiro Ohgawara; Satoshi Kubota; Harumi Kawaki; Naito Kurio; Tarek Abd El Kader; Mitsuhiro Hoshijima; Danilo Janune; Tsuyoshi Shimo; Bernard Perbal; Akira Sasaki; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2011-04-18       Impact factor: 5.782

5.  Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts.

Authors:  Andreea M Bujor; Sashidar Nakerakanti; Erin Morris; Faye N Hant; Maria Trojanowska
Journal:  Exp Dermatol       Date:  2010-02-25       Impact factor: 3.960

Review 6.  Autologous blood preparations rich in platelets, fibrin and growth factors.

Authors:  C Fioravanti; I Frustaci; E Armellin; R Condò; C Arcuri; L Cerroni
Journal:  Oral Implantol (Rome)       Date:  2016-07-23

Review 7.  Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer.

Authors:  Akinfemi Ayobami Akingboye; Stephen Giddins; Philip Gamston; Arthur Tucker; Harshad Navsaria; Constantions Kyriakides
Journal:  J Extra Corpor Technol       Date:  2010-03

8.  Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis.

Authors:  Abdellatif El-Seoudi; Tarek Abd El Kader; Takashi Nishida; Takanori Eguchi; Eriko Aoyama; Masaharu Takigawa; Satoshi Kubota
Journal:  J Cell Commun Signal       Date:  2017-03-25       Impact factor: 5.782

9.  Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression.

Authors:  Samuel A Black; Philip C Trackman
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

10.  Thrombopoietic-mesenchymal interaction that may facilitate both endochondral ossification and platelet maturation via CCN2.

Authors:  Kumi Sumiyoshi; Satoshi Kubota; Rika A Furuta; Kazuta Yasui; Eriko Aoyama; Harumi Kawaki; Kazumi Kawata; Toshihiro Ohgawara; Takashi Yamashiro; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.